Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Long-term Investment Intensity

Latest as of September 2019: 0.2%

Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Long-term Investment Intensity of 0.2% as of September 2019. Long-term investments of CN¥9.01 Million represent 0.2% of total assets of CN¥5.51 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Chengdu Kanghong Pharmaceuticals Group C reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

CN¥9.01 Million
CNY

Total Assets

CN¥5.51 Billion
CNY

Country

China
SHE

Chengdu Kanghong Pharmaceuticals Group Co Ltd Long-term Investment Intensity (2018–2018)

This chart shows how Chengdu Kanghong Pharmaceuticals Group Co Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of September 2019, the intensity stands at 0.2%, reflecting long-term investments of CN¥9.01 Million against total assets of CN¥5.51 Billion CNY. Explore 002773 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2018–2018)

The table below presents the year-by-year Long-term Investment Intensity for Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Chengdu Kanghong Pharmaceuticals Group C market capitalisation.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 0.2% CN¥9.50 Million CN¥5.19 Billion
pp = percentage points